Ascent Equity Partners invests in Instek's Series B funding round, positioning the metal 3D printing specialist for significant growth and an upcoming IPO.
Information on the Target
Instek, established in 2001, specializes in the manufacturing of metal 3D printers. It is primarily known for its innovative Direct Energy Deposition (DED) technology, which allows precise fusion of different metal powders such as iron, cobalt, and nickel using a laser. The company is a subsidiary of KorenTech, a firm focused on artificial joints, highlighting its expertise in both 3D printing technology and advanced materials processing.
Instek has distinguished itself in the competitive landscape with its proprietary CVM Powder Feeder technology, enabling the precise spraying of up to six types of metal powders during the DED process. This advanced technology has applications in producing aerospace components and high-performance medical devices, such as titanium-coated cobalt-chromium alloys used for artificial joint surfaces.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target’s Specific Country
In the South Korean market, the 3D printing industry has seen substantial growth and advancement, with a particular emphasis on metal printing applications. The demand for customized metal components is increasing across sectors,
Similar Deals
Goodwater Capital → Wrtn Technologies
2025
Ascent Equity Partners
invested in
Instech
in 2025
in a Series B deal